Post-Traumatic Stress Disorder and Depression Comorbidity: Severity Across Different Populations

Total Page:16

File Type:pdf, Size:1020Kb

Load more

REVIEW Post-traumatic stress disorder and depression comorbidity: severity across different populations Ravi Shah*1, Anu Shah2 & Paul Links1 Practice points Suffering a traumatic event is very common in our society and as much as 90% of the population may experience a traumatic event in their lifetime. Most people recover from a traumatic event and suffer no long-term difficulties; however, 8–12% may go on to develop post-traumatic stress disorder (PTSD). More than 50% of those diagnosed with PTSD also have depression. PTSD is very common in those who have been exposed to war, natural disaster and intimate partner violence when compared with the general population. PTSD and depression comorbidity develops as a delayed phenomenon in the latter part of the disease. Therefore, the timing of an assessment is a key factor that greatly affects the prevalence of PTSD and depression comorbidity. PTSD and depression comorbidity is often associated with greater levels of distress, symptomatology, social impairment, and occupational and global disability when compared with those who have been diagnosed with only one disorder (PTSD or depression). SUMMARY This review evaluates the impact of post-traumatic stress disorder (PTSD) and depression comorbidity on symptom severity within and across different populations. A sequential series of searches on PTSD and depression comorbidity was conducted using the MEDLINE and PsychINFO databases. Articles were considered for inclusion in the study if their abstract appeared to furnish sufficient information that suggested that symptom severity was modulated by PTSD and depression comorbidity when compared with those with only one disorder (PTSD or depression). After a careful review of 180 abstracts, 13 articles were selected for this review to provide up-to-date information on PTSD and depression comorbidity, and symptom severity. Overall, this review provides strong support for PTSD and depression comorbidity as a modulating factor for symptom severity across different populations. Suffering a traumatic event is very common in sequelae of traumatic events are depression our society, as suggested by many previous stud- and post-traumatic stress disorder (PTSD). ies [1–4] . Among the most commonly identified Approximately 50–90% of people experience a 1Suicide Studies Research Unit, St Michael’s Hospital, University of Toronto, Toronto, ON, Canada 2University of Toronto, Toronto, ON, Canada *Author for correspondence: Tel.: +1 416 864 6060 ext. 3127; Fax: +1 416 864 5996; [email protected] part of 10.2217/NPY.12.56 © 2012 Future Medicine Ltd Neuropsychiatry (2012) 2(6), 521–529 ISSN 1758-2008 521 REVIEW Shah, Shah & Links traumatic event in their lifetime; however, only impact of PTSD and depression comorbidity 8–12% of people will go on to develop PTSD on symptom severity, especially across different [3,5]. In the majority of cases (74%), PTSD per- populations [36,37]. Beside PTSD and depression sists longer than 6 months, and women have comorbidity, other factors associated with symp- been found to suffer from PTSD symptoms lon- tom severity are the type of trauma suffered, ger than men [5]. An individual’s vulnerability to severity of trauma, number of traumatic events, PTSD depends upon the severity of trauma [6], past psychiatric history, post-trauma social sup- childhood experiences, biological diathesis and port, peritraumatic emotional responses and comorbid factors such as personality disorders, peritraumatic dissociation [38]. substance abuse, medical illness or depression The main purpose of this study was to deter- [7]. Vasterling et al. demonstrated that the clini- mine whether a dual diagnosis of PTSD and cal impact of PTSD extends well beyond the depression is associated with greater symptom defined PTSD symptomatology boundary and severity compared with those who have been has been associated with a higher risk of somatic diagnosed with only one disorder (PTSD symptoms and medical illnesses [8]. Thus, PTSD or depression) across different populations. has a negative impact on an individual’s occupa- Although there are many factors associated tional and psychosocial functioning. Also, the with symptom severity, including PTSD and presence of PTSD predisposes individuals to depression comorbidity, there is no agreement comorbid depression [3,9–11] . in the literature on the generalizability of these Depression is a common mental illness that factors across different populations. Therefore, affects more than 20% of Americans at some the knowledge of population-specific find- point in their lifetime. Despite its high preva- ings would be more appropriate and helpful to lence in the general population, depression still address the clinical difficulties associated with remains misunderstood, under-reported and PTSD and depression comorbidity in different largely untreated [12] . The direct and indirect populations. impact of depression accounts for more than US$100 billion per year, which is ranked sec- Methods ond only to cancer [13,14] . Depression has been A sequential series of searches on PTSD and linked to multiple physical symptoms, unsat- depression comorbidity were conducted using isfactory health status and functioning, poor the MEDLINE and PsychINFO databases. Key- prognosis, and increased medical utilization words that were searched for included PTSD, and costs [13,15] . PTSD with depression is very symptom severity, comorbidity, depression, common in those who have been exposed to clinical or randomized or trial, workplace, men- war [16,17], disaster [18] and intimate partner tal health and psychological trauma. Literature violence (IPV) [19], when compared with the searches were then filtered using the following general population [20]. limiting factors: age (19–65 years), publication Over 80% of PTSD cases are comorbid with date (1980 to December 2011), human study and other mental disorders or medical illnesses [21] . English language to obtain appropriate and rel- The most commonly reported PTSD comorbid- evant articles. This search strategy was approved ities are anxiety, personality disorders, substance by a library scientist at St Michael’s Hospital. abuse, medical illness and depression [22–24]. The literature search resulted in 180 relevant The relationship between symptom severity abstracts. Articles were considered for inclusion and a dual diagnosis of PTSD and depression in the study if their abstract appeared to fur- has been frequently studied in diverse popula- nish sufficient information to examine whether tions such as the military, war victims, prison- symptom severity was modulated by PTSD ers, teachers, victims of domestic violence and and depression comorbidity, when compared those affected by a natural disaster [25–28]; in with those with only one disorder (PTSD or particular, the impact of PTSD and depres- depression). In this review, overall severity of sion comorbidity on symptom severity [2,29–37]. PTSD and/or depression symptomatology rep- Although many previous studies conducted resents the term symptom severity. Since this with traumatized populations have indicated review focuses on the adult working popula- adverse consequences of PTSD and depression tion, research on children and adolescents was comorbidity, including an increase in symptom excluded from the study. Articles that did not severity, studies are not consistent about the meet the inclusion criteria or provided very 522 Neuropsychiatry (2012) 2(6) future science group Post-traumatic stress disorder & depression comorbidity: severity across different populations REVIEW limited information about the impact of PTSD Articles by Trief et al. [39] and Ginzburg et al. and depression comorbidity on symptom sever- [25] were selected for the full review based on ity were excluded. In order to obtain reliable their abstracts but provided insufficient informa- information from rigorously conducted research, tion about the impact of PTSD and depression only original research articles published in comorbidity on symptom severity. The partici- peer-reviewed journals were included. Thus, pants in these studies were associated with multi- textbooks, book chapters, case reports, review ple comorbid illnesses; furthermore, these studies articles and unpublished doctoral dissertations did not analyze specifically the impact of PTSD were excluded from the study. and depression comorbidity on symptom severity. All abstracts gathered from the search process Therefore, these two studies were excluded from were reviewed carefully using the inclusion and this review. exclusion criteria decided upon by the authors. Inter-rater reliability for an article’s inclusion in Supportive findings of impact of the review was determined by comparing the comorbidity authors’ independent judgments regarding a Nixon et al. presented their findings of a cross- common set of 40 articles using the inclusion sectional study conducted on women recruited and exclusion criteria. Inter-rater reliability was from domestic violence assistance agencies and assessed using Cohen’s k-coefficient, which indi- shelters [26]. Women who had experienced inci- cated an acceptable level of inter-rater reliability dents of physical abuse 6 months prior to the (k = 0.75). The remaining abstracts were equally assessment were included in the study. The Cli- divided among the authors, reviewed based on nician-Administered PTSD Scale (CAPS) and the inclusion and exclusion criteria, and sub- the Structured Clinical Interview for DSM-IV sequently
Recommended publications
  • Guidelines for Treating Dissociative Identity Disorder in Adults, Third

    Guidelines for Treating Dissociative Identity Disorder in Adults, Third

    This article was downloaded by: [208.78.151.82] On: 21 October 2011, At: 09:20 Publisher: Routledge Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK Journal of Trauma & Dissociation Publication details, including instructions for authors and subscription information: http://www.tandfonline.com/loi/wjtd20 Guidelines for Treating Dissociative Identity Disorder in Adults, Third Revision International Society for the Study of Trauma and Dissociation Available online: 03 Mar 2011 To cite this article: International Society for the Study of Trauma and Dissociation (2011): Guidelines for Treating Dissociative Identity Disorder in Adults, Third Revision, Journal of Trauma & Dissociation, 12:2, 115-187 To link to this article: http://dx.doi.org/10.1080/15299732.2011.537247 PLEASE SCROLL DOWN FOR ARTICLE Full terms and conditions of use: http://www.tandfonline.com/page/terms-and-conditions This article may be used for research, teaching, and private study purposes. Any substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing, systematic supply, or distribution in any form to anyone is expressly forbidden. The publisher does not give any warranty express or implied or make any representation that the contents will be complete or accurate or up to date. The accuracy of any instructions, formulae, and drug doses should be independently verified with primary sources. The publisher shall not be liable for any loss, actions, claims, proceedings, demand, or costs or damages whatsoever or howsoever caused arising directly or indirectly in connection with or arising out of the use of this material.
  • Comorbid Psychiatric Disorders in Children with Autism: Interview Development and Rates of Disorders

    Comorbid Psychiatric Disorders in Children with Autism: Interview Development and Rates of Disorders

    J Autism Dev Disord (2006) 36:849–861 DOI 10.1007/s10803-006-0123-0 ORIGINAL PAPER Comorbid Psychiatric Disorders in Children with Autism: Interview Development and Rates of Disorders Ovsanna T. Leyfer Æ Susan E. Folstein Æ Susan Bacalman Æ Naomi O. Davis Æ Elena Dinh Æ Jubel Morgan Æ Helen Tager-Flusberg Æ Janet E. Lainhart Published online: 15 July 2006 Ó Springer Science+Business Media, Inc. 2006 Abstract The Kiddie Schedule for Affective Disorders sample demonstrated a high prevalence of specific phobia, and Schizophrenia was modified for use in children and obsessive compulsive disorder, and ADHD. The rates of adolescents with autism by developing additional screening psychiatric disorder in autism are high and are associated questions and coding options that reflect the presentation of with functional impairment. psychiatric disorders in autism spectrum disorders. The modified instrument, the Autism Comorbidity Interview- Keywords Psychopathology Æ Autism Æ Psychiatric Present and Lifetime Version (ACI-PL), was piloted and interview Æ Comorbidity frequently diagnosed disorders, depression, ADHD, and OCD, were tested for reliability and validity. The ACI-PL provides reliable DSM diagnoses that are valid based on clinical psychiatric diagnosis and treatment history. The Children with autism frequently have problematic emo- tional reactions and behaviors along with the features that O. T. Leyfer Department of Psychological and Brain Sciences, University define autism. Disturbances of emotion, attention, activity, of Louisville, Louisville, KY, USA and thought, and associated behavioral problems occur in children with autism of all ages (Lainhart, 1999). It is not S. E. Folstein yet known how often these additional difficulties are due to Department of Psychiatry, Johns Hopkins University, Baltimore, MD, USA comorbid psychiatric disorders.
  • The Impact of Paradoxical Comorbidities on Risk-Adjusted

    The Impact of Paradoxical Comorbidities on Risk-Adjusted

    MMRR 2011: Volume 1 (3) Medicare & Medicaid Research Review 2011: Volume 1, Number 3 A publication of the Centers for Medicare & Medicaid Services, Center for Strategic Planning Mary S. Vaughan-Sarrazin,1,2 Xin Lu,2 and Peter Cram 2 ¹Iowa City Veterans Administration Medical Center Center for Comprehensive Access and Delivery Research and Evaluation (CADRE) ²University of Iowa Carver College of Medicine, Department of Internal Medicine Division of General Internal Medicine The impact of paradoxical comorbidities on risk- adjusted mortality of Medicare beneficiaries with cardiovascular disease Abstract Background: Persistent uncertainty remains regarding assessments of patient comorbidity based on administrative data for mortality risk adjustment. Some models include comorbid conditions that are associated with improved mortality while other models exclude these so-called paradoxical conditions. The impact of these conditions on patient risk assessments is unknown. Objective: To examine trends in the prevalence of conditions with a paradoxical (protective) relationship with mortality, and the impact of including these conditions on assessments of risk adjusted mortality. Methods: Patients age 65 and older admitted for acute myocardial infarction (AMI) or coronary artery bypass graft (CABG) surgery during 1994 through 2005 were identified in Medicare Part A files. Comorbid conditions defined using a common algorithm were categorized as having a paradoxical or non-paradoxical relationship with 30-day mortality, based upon regression coefficients in multivariable logistic regression models. Results: For AMI, the proportion of patients with one or more paradoxical condition and one or more non-paradoxical condition increased by 24% and 3% respectively between 1994 and 2005. The odds of death for patients with one-or-more paradoxical comorbidities, relative to patients with no paradoxical comorbidity, declined from 0.69 to 0.54 over the study period.
  • An Empirical Examination of Six Myths About Dissociative Identity Disorder Bethany L

    An Empirical Examination of Six Myths About Dissociative Identity Disorder Bethany L

    PERSPECTIVES Separating Fact from Fiction: An Empirical Examination of Six Myths About Dissociative Identity Disorder Bethany L. Brand, PhD, Vedat Sar, MD, Pam Stavropoulos, PhD, Christa Krüger, MB BCh, MMed (Psych), MD, Marilyn Korzekwa, MD, Alfonso Martínez-Taboas, PhD, and Warwick Middleton, MB BS, FRANZCP, MD Abstract: Dissociative identity disorder (DID) is a complex, posttraumatic, developmental disorder for which we now, after four decades of research, have an authoritative research base, but a number of misconceptualizations and myths about the disorder remain, compromising both patient care and research. This article examines the empirical literature pertaining to recurrently expressed beliefs regarding DID: (1) belief that DID is a fad, (2) belief that DID is primarily diag- nosed in North America by DID experts who overdiagnose the disorder, (3) belief that DID is rare, (4) belief that DID is an iatrogenic, rather than trauma-based, disorder, (5) belief that DID is the same entity as borderline personality disorder, and (6) belief that DID treatment is harmful to patients. The absence of research to substantiate these beliefs, as well as the existence of a body of research that refutes them, confirms their mythical status. Clinicians who accept these myths as facts are unlikely to carefully assess for dissociation. Accurate diagnoses are critical for appropriate treatment planning. If DID is not targeted in treatment, it does not appear to resolve. The myths we have highlighted may also impede research about DID. The cost of ignorance about DID is high not only for individual patients but for the whole support system in which they reside.
  • Medical Comorbidities in Autism Spectrum Disorders

    Medical Comorbidities in Autism Spectrum Disorders

    TA-ESPA-ATP PAPER 2014 1st draft_Layout 1 21/07/2014 19:21 Page 1 Medical Comorbidities in Autism Spectrum Disorders A Primer for Health Care Professionals and Policy Makers Second Edition: July 2014 Prepared by: l Treating Autism l ESPA Research l Autism Treatment Plus TA-ESPA-ATP PAPER 2014 1st draft_Layout 1 21/07/2014 19:21 Page 2 Treating Autism , a charity run entirely by volunteers, provides information and support to families and individuals affected by autism with the aim of improving their quality of life. Registered Charity: www.treatingautism.co.uk No. 1113628, Limited Company Registered in England: No. 5594787. ESPA Research is a not-for-profit subsidiary of ESPA (Education and Services for People with Autism) dedicated to undertaking high-quality research into autism and related conditions all for the public benefit. www.espa-research.org.uk ESPA Research Ltd. Company registration: 6862992. ESPA Registered Charity No. 1037868 | Company No. 2909953 Autism Treatment Plus, dedicated to helping individuals with autism reach optimal health and learning, provides access to diagnostic, medical and behavioural services. www.autismtreatment.org.uk. Limited company registered in England: No. 08623707. © Treating Autism Publications, 2014 Second edition, published July 2014. (First edition published March 2013). All rights reserved. Reproduction of this report, in its entirety and unaltered, by photocopying or electronic means for noncommercial purposes is permitted. Otherwise, no part of this report may be reproduced, adapted, stored in a retrieval system or transmitted by any means, electronic, mechanical, photocopying, or otherwise without the prior written permission of Treating Autism Publications. ISBN: 978-0-9575787-2-2 A pdf version of this publication is available from the Treating Autism website www.treatingautism.co.uk.
  • The Comorbidity of PTSD and MDD: Implications for Clinical Practice and Future Research

    The Comorbidity of PTSD and MDD: Implications for Clinical Practice and Future Research

    The Comorbidity of PTSD and MDD: Implications for Clinical Practice and Future Research Samantha Angelakis and Reginald D.V. Nixon School of Psychology, Flinders University, Adelaide, South Australia, Australia The high prevalence of post-traumatic stress disorder (PTSD) and major depressive disorder (MDD) comorbidity is well established, with comorbidity rates often be- tween 30 and 50%. However, despite the high prevalence of this comorbidity, very few researchers have explored specific treatments for individuals who present with comorbid PTSD and MDD. Further, there has not been explicit examination of the mechanisms through which MDD influences trauma-focused therapy. As individ- uals with comorbid PTSD and MDD often present with a more chronic course of impairment and in some instances, a more delayed response to treatment, the need for such research is imperative. It will be proposed that there is merit in targeting depression within the treatment of comorbid PTSD and MDD. Accordingly, in this article we review explanations for the high PTSD and MDD comorbid relationship and highlight variables likely to explain such comorbidity. Theoretical accounts for how depression impedes optimal recovery from PTSD and the associated empirical findings are illustrated. We consequently argue that there is a need to develop and test treatments that target both PTSD and MDD symptoms. Directions for future research are highlighted. Keywords: PTSD, MDD, comorbidity, treatment, emotional engagement It is well established that post-traumatic stress disorder (PTSD) often co-occurs with depression. Over a range of sample and trauma types it has been observed that 30– 50% of individuals with PTSD also meet the criteria for a diagnosis of depression (Creamer, Burgess, & McFarlane, 2001; Kessler, Berglund et al., 2005).
  • Comorbidities Among US Patients with Prevalent HIV Infection—A Trend Analysis Joel Gallant,1 Priscilla Y

    Comorbidities Among US Patients with Prevalent HIV Infection—A Trend Analysis Joel Gallant,1 Priscilla Y

    The Journal of Infectious Diseases MAJOR ARTICLE Comorbidities Among US Patients With Prevalent HIV Infection—A Trend Analysis Joel Gallant,1 Priscilla Y. Hsue,2 Sanatan Shreay,3 and Nicole Meyer4 1Southwest CARE Center, Santa Fe, New Mexico; 2University of California San Francisco, San Francisco, and 3Gilead Sciences, Foster City, California; and 4Truven Health Analytics, Cambridge, Massachusetts Objective. Quantify proportion of human immunodeficiency virus (HIV)–infected patients with specific comorbidities receiv- ing healthcare coverage from commercial, Medicaid, and Medicare payers. Methods. Data from MarketScan research databases were used to select adult HIV-infected patients from each payer. Treated HIV-infected patients were matched to HIV-negative controls. Cross-sectional analyses were performed between 2003 and 2013 among HIV-infected patients to quantify the proportion with individual comorbidities over the period, by payer. XX Results. Overall, 36 298 HIV-infected patients covered by commercial payers, 26 246 covered by Medicaid payers, and 1854 covered by Medicare payers were identified between 2003 and 2013. Essential hypertension (31.4%, 39.3%, and 76.2%, respectively), XXXX hyperlipidemia (29.2%, 22.1%, and 49.6%), and endocrine disease (21.8%, 27.2%, and 54.0%) were the most common comorbidities. Comparison of data from 2003 to data from 2013 revealed significant increases across payers in the percentage of patients with the comorbidities specified above (P < .05). Across all payers, the proportions of treated HIV-infected patients with deep vein throm- bosis, hepatitis C, renal impairment, thyroid disease, and liver disease from 2003 to 2013 was significantly greater (P < .05) than for matched controls. Conclusions.
  • The Comorbidity of ADHD and Autism Spectrum Disorders (Asds) in Community Preschoolers

    The Comorbidity of ADHD and Autism Spectrum Disorders (Asds) in Community Preschoolers

    Chapter 6 The Comorbidity of ADHD and Autism Spectrum Disorders (ASDs) in Community Preschoolers Maria Carmen Carrascosa-Romero and Carlos De Cabo- De La Vega Additional information is available at the end of the chapter http://dx.doi.org/10.5772/61400 Abstract Symptoms of inattention and hyperactivity, features of attention-deficit/hyperactivity disorder (ADHD), have been frequently documented in children with autism spec‐ trum disorders (ASDs) and often co-occur. Evidence indicates that 20-50% of children with ADHD meet criteria for ASD, and 30-80% of ASD children meet criteria for ADHD. According to the DSM-IV, the essential features of Autistic Disorder (AD) are “the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interests”. Differ‐ ential diagnosis of “Pervasive Developmental Disorder” (PDD: Autistic Disorder, Re‐ tt's Disorder, Childhood Disintegrative Disorder, Asperger's Disorder) and “Pervasive Developmental Disorder-Not Otherwise Specified”(PDD-NOS) is often difficult in the preschool child. This is particularly true when assessing verbal and nonverbal com‐ munication since both expressive and cognitive language are not yet established and there are many differences in their acquisition period among these children (before the age of three). As a result, many of these children are diagnosed with PDD-NOS not meeting the criteria for a specific type of PDD; this category includes "atypical au‐ tism" presentations that do not meet the criteria for AD. As a result, the concept of PDD-NOS has become a mixed bag. Often, diagnosis cannot be established before age three, delaying therapeutic interventions.
  • Psychiatric Comorbidities in Asperger Syndrome and High Functioning Autism: Diagnostic Challenges Luigi Mazzone1*, Liliana Ruta2 and Laura Reale3

    Psychiatric Comorbidities in Asperger Syndrome and High Functioning Autism: Diagnostic Challenges Luigi Mazzone1*, Liliana Ruta2 and Laura Reale3

    Mazzone et al. Annals of General Psychiatry 2012, 11:16 http://www.annals-general-psychiatry.com/content/11/1/16 REVIEW Open Access Psychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challenges Luigi Mazzone1*, Liliana Ruta2 and Laura Reale3 Abstract Several psychiatric conditions, both internalizing and externalizing, have been documented in comorbidity with Asperger Syndrome (AS) and High Functioning Autism (HFA). In this review we examine the interplay between psychiatric comorbidities and AS/HFA. In particular, we will focus our attention on three main issues. First, we examine which psychiatric disorders are more frequently associated with AS/HFA. Second, we review which diagnostic tools are currently available for clinicians to investigate and diagnose the associated psychiatric disorders in individuals with AS/HFA. Third, we discuss the challenges that clinicians and researchers face in trying to determine whether the psychiatric symptoms are phenotypic manifestations of AS/HFA or rather they are the expression of a distinct, though comorbid, disorder. We will also consider the role played by the environment in the manifestation and interpretation of these symptoms. Finally, we will propose some strategies to try to address these issues, and we will discuss therapeutic implications. Keywords: Asperger, High functioning autism, Comorbidities, Diagnostic challenges Introduction challenge for clinicians and families and the psychiatric Asperger Syndrome (AS) and High Functioning Autism symptoms in
  • Medical Comorbidity in Schizophrenia

    Medical Comorbidity in Schizophrenia

    VOL 22, NO. 3, 1996 Medical Comorbidity in 413 Schizophrenia by Dilip V. Jeste, Abstract Mens sana in corpore sano. Downloaded from https://academic.oup.com/schizophreniabulletin/article/22/3/413/1829806 by guest on 24 September 2021 Julie Aklko Gladsjo, (Sound mind in a sound body.) Laurie A. Undamer, and The extent and consequences of [Juvenal, 2nd Century A.D.; cited Jonathan P. Lacro medical comorbidity in patients in New Encyclopedia Britannica, with schizophrenia are generally 1993, p. 667] underrecognized. Patients with comorbid conditions are usually excluded from research studies, although they probably represent The comorbidity of physical and the majority of individuals with mental illnesses has implications for the treatment, health care utilization schizophrenia. Elderly patients are and cost, quality of life, and under- especially likely to have comorbid standing of the pathophysiology of disorders. In this article, we review those disorders. A number of studies selected literature on medical have examined the relationship comorbidity in schizophrenia, between depression and physical ill- including physical illnesses, sub- nesses (see Schulberg et al. 1987). stance use, cognitive impairment, Medical comorbidity in schizophre- sensory deficits, and iatrogenic nia, however, has been studied to a comorbidity. Data from the Univer- much smaller extent. sity of California, San Diego Clini- cal Research Center on late-life psy- chosis are also presented. Older Anosognosia for Medical schizophrenia patients report fewer Comorbidity In Schizophrenia? comorbid physical illnesses than healthy comparison subjects, but Anosognosia is broadly defined as their illnesses tend to be more ignorance, real or feigned, of the severe. These results suggest that presence of disease (specifically of schizophrenia patients may receive paralysis) (Stedman 1990).
  • Trauma, Posttraumatic Stress Disorder and Eating Disorders Written by Timothy D

    Trauma, Posttraumatic Stress Disorder and Eating Disorders Written by Timothy D

    Trauma, Posttraumatic Stress Disorder and Eating Disorders Written by Timothy D. Brewerton, MD, DFAPA, FAED, DFAACPA, HEDS Traumatic events are events that cause psychological, physical and/or emotional pain or harm. Traumatic events, especially those involving violence between people, have been found to be significant risk factors for the development of a variety of psychiatric disorders, including eating disorders—particularly those involving bulimic symptoms, such as binge eating and purging. Stress, Trauma and Coping Stress is an unavoidable part of life, but sometimes when stress becomes overwhelming and overpowers our coping mechanisms (such as talking to a friend, meditating or journaling) it causes distress, disease and dysfunction. Generally, when stress reaches the point where it causes emotional and/or physical problems, then it becomes traumatic. What is “traumatic” to any given individual is best understood in light of the “three E’s,” i.e., Event, Experience, and Effects, an important point made by the Substance Abuse and Mental Health Services Administration (SAMHSA, 2014). Some people are at increased risk of stress, trauma or negative events. This is determined by a combination of biological, psychological and social factors, such as being prone to anxiety and/or depression and/or having inherited the personality traits of high harm avoidance (shy, fearful, worrying behavior) and/or acting on an impulse. What may seem to be of little or no concern to one person can be very traumatic to another, particularly to one with, or predisposed to, an eating disorder. How we cope with stress can play an important role in whether or not stressful experiences become traumatic.
  • Comorbidity of Post-Traumatic Stress Symptoms and Depressive Symptoms Among Obstetric Nurses with Perinatal Death Exposure

    Comorbidity of Post-Traumatic Stress Symptoms and Depressive Symptoms Among Obstetric Nurses with Perinatal Death Exposure

    Isr J Psychiatry Relat Sci - Vol. 53 - No 2 (2016) Comorbidity of Post-traumatic Stress Symptoms and Depressive Symptoms among Obstetric Nurses with Perinatal Death Exposure Yaira Hamama-Raz, PhD,1 Reut Walker, MA,1 Yuval Palgi, PhD,2 Reuven Mashiach, MD,3 Karin Lee-Ovadia, MsC,4 Ariel Manny, MD,5 and Menachem Ben-Ezra, PhD1 1 School of Social Work, Ariel University, Ariel, Israel 2 Department of Gerontology, University of Haifa, Haifa, Israel 3 Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, Israel 4 Division of Obstetrics and Gynecology, Assaf Harofe Medical Center, Be’er Ya’akov, Israel 5 Labor and Delivery Unit, Sourasky Medical Center, Tel Aviv, Israel INTRODUCTION ABSTRACT The bliss of birth in midwifery practice is sometimes replaced Background: Mental health and well-being among by the tragedy of perinatal death. Caring for and support- obstetric nurses after perinatal death is understudied. The ing parents whose fetus has died is extremely demanding, primary goal of this study is to explore the comorbidity painful and stressful (1, 2). Hence, some obstetric nurses of post-traumatic stress disorder (PTSD) symptoms may experience difficulties providing supportive care in and depressive symptoms among obstetric nurses. In this area of their professional practice (3). The effects of addition, we explore associations between personal perinatal death on obstetric nurses’ comorbidity and their resources – coping self-efficacy and active social support practice remains largely understudied (4). Two studies, – and comorbidity symptoms. conducted by Chan et al. (1, 5), which measured nurses’ Method: One hundred and twenty-five obstetric nurses general attitudes toward perinatal death revealed that their who represent 25% of the entire population of Israeli attitudes were positively correlated with training needs and obstetric nurses completed self-report questionnaires hospital policy support.